Exelixis
| Use attributes for filter ! | |
| Stock price | EXEL |
|---|---|
| Disclaimer | |
| Headquarters | Alameda |
| California | |
| United States | |
| Revenue | 853. 8 million USD (2018) |
| Number of employees | 507 |
| Founders | Stelios Papadopoulos |
| Corey S. Goodman | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 844720 |
About Exelixis
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U. S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
